Sales rise 6.93% to Rs 790.15 crore
Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales790.15738.95 7 OPM %36.4835.80 -PBDT241.75209.59 15 PBT172.67129.11 34 NP120.1991.59 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
